126 related articles for article (PubMed ID: 2947742)
1. The vasodilator potency of atrial natriuretic peptide in man.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Ritz R; Bühler FR
Circulation; 1987 Jan; 75(1):221-8. PubMed ID: 2947742
[TBL] [Abstract][Full Text] [Related]
2. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
Fujita T; Ito Y; Noda H; Sato Y; Ando K; Kangawa K; Matsuo H
J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
[TBL] [Abstract][Full Text] [Related]
3. Attenuated forearm vasodilator response to atrial natriuretic factor in the elderly.
Jansen TL; Smits P; Tan AC; Thien T
Hypertension; 1991 Nov; 18(5):640-7. PubMed ID: 1657770
[TBL] [Abstract][Full Text] [Related]
4. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
Müller FB; Erne P; Raine AE; Bolli P; Linder L; Resink TJ; Cottier C; Bühler FR
J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
[TBL] [Abstract][Full Text] [Related]
5. Impaired vasodilator response to atrial natriuretic factor in IDDM.
Smits P; Hersbach FM; Jansen TL; Thien T; Lutterman JA
Diabetes; 1993 Oct; 42(10):1454-61. PubMed ID: 8397129
[TBL] [Abstract][Full Text] [Related]
6. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
[TBL] [Abstract][Full Text] [Related]
7. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.
van der Zander K; Houben AJ; Kroon AA; de Leeuw PW
Cardiovasc Res; 1999 Dec; 44(3):595-600. PubMed ID: 10690292
[TBL] [Abstract][Full Text] [Related]
8. Vascular effects of natriuretic peptides in healthy men.
Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
[TBL] [Abstract][Full Text] [Related]
9. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
Cody RJ; Müller FB; Kubo SH; Rutman H; Leonard D
Circulation; 1986 Jan; 73(1):124-9. PubMed ID: 3940663
[TBL] [Abstract][Full Text] [Related]
10. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide.
Ando K; Ito Y; Ogata E; Fujita T
Am Heart J; 1992 Jan; 123(1):111-6. PubMed ID: 1530893
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor as a vasodilator agent in hypertensive patients.
Pedrinelli R; Spessot M; Panarace G; Taddei S; Favilla S; Salvetti A
Am J Med Sci; 1990 Aug; 300(2):78-82. PubMed ID: 2144948
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the vasodilatory effects of sodium nitroprusside vs. nitroglycerin.
Ranadive SM; Eugene AR; Dillon G; Nicholson WT; Joyner MJ
J Appl Physiol (1985); 2017 Aug; 123(2):402-406. PubMed ID: 28572495
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of reflex forearm vasoconstriction by alpha-human atrial natriuretic peptide in men.
Takeshita A; Imaizumi T; Nakamura N; Higashi H; Sasaki T; Nakamura M; Kangawa K; Matsuo H
Circ Res; 1987 Oct; 61(4):555-9. PubMed ID: 2958168
[TBL] [Abstract][Full Text] [Related]
14. The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humans.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S75-9. PubMed ID: 2473356
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide increases human capillary filtration and venous distensibility.
Ando S; Imaizumi T; Harada S; Hirooka Y; Takeshita A
J Hypertens; 1992 May; 10(5):451-7. PubMed ID: 1317906
[TBL] [Abstract][Full Text] [Related]
16. Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Bühler FR
J Hypertens Suppl; 1987 Dec; 5(5):S55-8. PubMed ID: 2965230
[TBL] [Abstract][Full Text] [Related]
17. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
Doorenbos CJ; Blauw GJ; van Brummelen P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
[TBL] [Abstract][Full Text] [Related]
18. Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels.
Minami H; Yasu T; Tagawa T; Yamakawa K; Ueda S
Eur J Clin Pharmacol; 2008 Sep; 64(9):859-62. PubMed ID: 18622600
[TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-human atrial natriuretic peptide on the interrelationship of arterial pressure, aortic nerve activity, and aortic diameter.
Hirooka Y; Takeshita A; Imaizumi T; Nakamura N; Tomoike H; Nakamura M
Circ Res; 1988 Dec; 63(6):987-96. PubMed ID: 2973847
[TBL] [Abstract][Full Text] [Related]
20. Barium reduces resting blood flow and inhibits potassium-induced vasodilation in the human forearm.
Dawes M; Sieniawska C; Delves T; Dwivedi R; Chowienczyk PJ; Ritter JM
Circulation; 2002 Mar; 105(11):1323-8. PubMed ID: 11901043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
